https://orcid.org/0000-0002-6606-9460
Overview
Prognostic indicators for patients with Candida spp. bloodstream infections
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Antifungal pharmacokinetics/pharmacodynamics
Immunogenetics among patients with candidiasis
Management of the HIV infected patient and antiretroviral pharmacotherapy
Antibacterial drug utilization, resistance, and appropriate prescribing
Antimicrobial Stewardship
Current Appointments & Affiliations
Professor in Medicine
·
2022 - Present
Medicine, Infectious Diseases,
Medicine
Recent Publications
Comprehensive Review of Candidozyma (Candida) auris Management: Insights From the Society of Infectious Diseases Pharmacists.
Journal Article Pharmacotherapy · April 2026 Candidozyma (Candida) auris has emerged over the past two decades as a formidable global health threat due to its multidrug resistance, persistence in healthcare environments, and rapid nosocomial spread. Recently reclassified into the genus Candidozyma ba ... Full text Link to item CiteConcurrent Administration of Triazoles with Chemotherapeutic and/or Immunosuppressant Agents Known to Have Moderate-to-Severe Drug-Drug Interactions in Patients with Hematologic Malignancies Hospitalized for Invasive Aspergillosis.
Journal Article Mycopathologia · January 13, 2026 BACKGROUND: Triazoles are widely used for treatment and prevention of invasive aspergillosis (IA) but can cause serious drug-drug interactions (DDIs) with chemotherapeutic (CT) and immunosuppressant (IS) agents via CYP3A4 inhibition. The frequency of triaz ... Full text Link to item CiteCo-administration of triazoles with calcineurin or mammalian target of rapamycin inhibitors in solid organ transplant patients hospitalized with invasive aspergillosis.
Journal Article J Antimicrob Chemother · January 6, 2026 BACKGROUND: All triazoles decrease the metabolism of calcineurin inhibitors (CNIs) and mammalian target of rapamycin (mTOR) inhibitors through CYP3A4 and P-glycoprotein inhibition leading to increased exposure and the potential for serious adverse events ( ... Full text Link to item CiteRecent Grants
Tri-Institutional Molecular Mycology and Pathogenesis Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Systems Biology for Infectious Diseases
ResearchPrincipal Investigator · Awarded by The Lundquist Institute · 2023 - 2028Host directed medicine in invasive fungal infection - HDM-FUN
Clinical TrialCo Investigator · Awarded by European Union · 2020 - 2026View All Grants
Education
Duke University, School of Medicine ·
2007
M.H.S.
Campbell University ·
1997
Pharm.D.
Duke University, School of Medicine ·
1992
B.S.